Skip to main content Accessibility help
×
Hostname: page-component-8448b6f56d-tj2md Total loading time: 0 Render date: 2024-04-20T01:00:44.369Z Has data issue: false hasContentIssue false

Section V - Leucocyte Disorders

Published online by Cambridge University Press:  30 January 2021

Pedro A. de Alarcón
Affiliation:
University of Illinois College of Medicine
Eric J. Werner
Affiliation:
Children's Hospital of the King's Daughters
Robert D. Christensen
Affiliation:
University of Utah
Martha C. Sola-Visner
Affiliation:
Harvard University, Massachusetts
Get access

Summary

Eosinophilia in neonates is identified when the blood concentration of eosinophils exceeds the upper reference range limit. To avoid the potential pitfall of laboratory or technician error, perhaps the definition should be two subsequent eosinophil counts above the upper reference limit. The 95th percentile for blood concentration of eosinophils increases slightly over the first month following birth. Initially a count ≥1,200/µL would exceed the upper range, and by about four weeks a count of above 1,500/µL would exceed the upper limit [1]. This latter value is similar to that generally used to define eosinophilia in adults [2]. Adults with persistent eosinophilia are well advised to have the situation evaluated, because an association has been seen between persistent eosinophilia and end-organ damage [2]. Some adults with persistent eosinophilia have elevated blood Interkeukin-5 (IL-5) concentrations [3]. Some with hypereosinophilic syndrome have an eosinophilic leukemia involving a translocation in the tyrosine kinase gene [4].

Type
Chapter
Information
Neonatal Hematology
Pathogenesis, Diagnosis, and Management of Hematologic Problems
, pp. 261 - 292
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Christensen, RD, Jensen, J, Maheshwari, A, Henry, E. Reference ranges for blood concentrations of eosinophils and monocytes during the neonatal period defined from over 63,000 records in a multihospital health-care system. J Perinatol 2010;30(8):540–5.Google Scholar
McCurley, TL, Greer, JP. Diagnostic approach to malignant and nonmalignant disorders of the phagocytic and immune systems. In Greer, JP, Foerster, J, Rodgers, GM, et al. eds. Wintrobe’s Clinical Hematology (Philadelphisa PA: Lippincott/Williams & Wilkins: 2009), pp. 1513–14.Google Scholar
Simon, HU, Plotz, SG, Dummer, R, et al. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999;341(15):1112–20.Google Scholar
Gotlib, J. Molecular classification and pathogenesis of eosinophilic disorders: 2005 update. Acta Haematol 2005;114(1):725.Google Scholar
Lee, NA, McGarry, MP, Larson, KA, et al. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J Immunol 1997;158(3):1332–44.Google Scholar
Dent, LA, Strath, M, Mellor, AL, Sanderson, CJ. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990;172(5):1425–31.CrossRefGoogle ScholarPubMed
Rennick, DM, Thompson, -Snipes, L, Coffinan, RL, et al. In vivo administration of antibody to interleukin-5 inhibits increased generation of eosinophils and their progenitors in bone marrow of parasitized mice. Blood 1990; 76(2):312–16.Google Scholar
Sher, A, Coffman, RL, Hieny, S, et al. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc Natl Acad Sci USA 1990;87(1):61–5.Google Scholar
Lu, L, Lin, ZN, Shen, RN, et al. Influence of interleukins 3,5, and 6 on the growth of eosinophil progenitors in highly enriched human bone marrow in the absence of serum. Exp Hematol 1990;18(11):1180–6.Google Scholar
Brugnoni, D, Airo, R, Rossi, G, et al. A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5. Blood 1996;87(4):1416–22.Google Scholar
Okayama, H, Fushimi, T, Sllimura, S, et al. Glucocorticoids suppressed production and gene expression of interleukin-5 by peripheral blood mononuclear cells in atopic patients and normal subjects. J Allergy Clin Immunol 1994;93(6):1006–12.Google Scholar
Krishnaswamy, G, Smith, J, Srikandl, S, et al. Lymphoblastoid interferon-alpha inhibits T cell proliferation and expression of eosinophil-activating cytokines. J Interferon Cytokine Res 1996;16(10):819–27.Google Scholar
Walsh, GM, Hartnell, A, Wardlaw, AJ, et al. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Immunology 1990;71(2):258–65.Google Scholar
Medoff, HS, Barbero, GJ. Total blood eosinophil counts in the newborn period. Pediatrics 1950;6(5):737–42.Google Scholar
Xanthou, M. Leucocyte blood picture in ill newborn babies. Arch Dis Child 1972;47(255):741–6.Google Scholar
Burrell, JM. A comparative study of the circulating eosinophil level in babies. Part I. Premature infants. Arch Dis Child 1952;27(134):337–40.Google Scholar
Bass, DA. Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation. J Clin Invest 1975;56(4):870–9.Google Scholar
Gibson, EL, Vaucher, Y, Corrigan, JJ Jr. Eosinophilia in premature infants: Relationship to weight gain. J Pediatr 1979;95(1):99101.Google Scholar
Portuguezmalavasi, A, Coteboileau, T, Aranda, JV. Eosinophilia in the newborn, possible role in adverse drug-reactions. Pediatrc Res 1980;14(4):537–8.Google Scholar
Craver, RD. The cytology of cerebrospinal fluid associated with neonatal intraventricular hemorrhage. Pediatr Pathol Lab Med 1996;16(5):713–19.Google Scholar
Patel, L, Garvey, B, Arnon, S, Roberts, IA. Eosinophilia in newborn infants. Acta Paediatr 1994;83(8):797801.Google Scholar
Odelram, H, Bjorksten, B, Leander, E, Kjellman, NI. Predictors of atopy in newborn babies. Allergy 1995;50(7):585–92.Google Scholar
Yamamoto, C, Kojima, T, Hatrori, K, et al. Eosinophilia in premature infants: Correlation with chronic lung disease. Acta Paediatrica 1996;85(10):1232–5.Google Scholar
Morgan, AJ, Steen, CJ, Schwartz, RA, Janniger, CK. Erythema toxicum neonatorum revisited. Cutis 2009;83(1):13–16.Google Scholar
Matsumoto, K, Shimanouchi, Y, Kawakubo, K, et al. Infantile eczema at one month of age is associated with cord blood eosinophilia and subsequent development of atopic dermatitis and wheezing illness until two years of age. Int Arch Allergy Immunol 2005;137 Suppl 1:6976.Google Scholar
Marchini, G, Ulfgren, AK, Loré, K, et al. Erythema toxicum neonatorum: An immunohistochemical analysis. Pediatr Dermatol 2001;18(3):177–87.Google Scholar
Ladrigan, MK, LeBoit, PE, Frieden, IJ. Neonatal eosinophilic pustulosis in a 2-month old. Pediatr Dermatol 2008;25(1):52–5.Google Scholar
Asgari, M, Leiferman, KM, Piepkorn, M, Kuechle, MK. Neonatal eosinophilic pustulosis. Int J Dermatol 2006;45(2):131–4.Google Scholar
Chiang, YC, Shyur, SD, Huang, LH, et al. Chlamydia trachomatis pneumonia: Experience in a medical center. Acta Paediatr Taiwan 2005;46(5):284–8.Google Scholar
Lindemans, CA, Kimpen, JL, Luijk, B, et al. Systemic eosinophil response induced by respiratory syncytial virus. Clin Exp Immunol 2006;144(3):409–17.Google Scholar
Brostrom, EB, Katz, -Salamon, M, Lundahl, J, Halldén, G, Winbladh, B. Eosinophil activation in preterm infants with lung disease. Acta Paediatr, 2007;96(1):23–8.Google Scholar
Pentiuk, SP, Miller, CK, Kaul, A. Eosinophilic esophagitis in infants and toddlers. Dysphagia 2007;22(1):44–8.Google Scholar
Ohtsuka, Y, Shimizu, T, Shoji, H, et al. Neonatal transient eosinophilic colitis causes lower gastrointestinal bleeding in early infancy. J Pediatr Gastroenterol Nutr 2007;44(4):501–5.Google Scholar
Tajirian, A, Ross, R, Zeikus, P, Robinson, -Bostom, L. Subcutaneous fat necrosis of the newborn with eosinophilic granules. J Cutan Pathol 2007;34(7):588–90.Google Scholar
Juul, SE, Haynes, JW, McPherson, RJ. Evaluation of eosinophilia in hospitalized preterm infants. J Perinatol 2005;25(3):182–8.Google Scholar
Carballo, C, Foucar, K, Swanson, P, Papile, LA, Watterberg, KL. Effect of high altitude on neutrophil counts in newborn infants. J Pediatr 1991;119(3):464–6.Google Scholar
Maynard, EC, Reed, C, Kircher, T. Neutrophil counts in newborn infants at high altitude. J Pediatr 1993;122(6):990–1.Google Scholar
Schmutz, N, Henry, E, Jopling, J, Christensen, RD. Expected ranges for blood neutrophil concentrations of neonates: The Manroe and Mouzinho charts revisited. J Perinatol 2008;28(4):275–81.Google Scholar
Manroe, BL, Weinberg, AG, Rosenfeld, CR, Browne, R. The neonatal blood count in health and disease. I. Reference values for neutrophilic cells. J Pediatr 1979;95(1):8998.Google Scholar
Mouzinho, A, Rosenfeld, CR, Sanchez, PJ, Risser, R. Revised reference ranges for circulating neutrophils in very-low-birth-weight neonates. Pediatrics 1994;94(1):7682.Google Scholar
Manroe, BL. Neutrophil values in infants born at high altitudes. J Pediatr 1992;120(2 Pt 1):334–5.Google Scholar
Xanthou, M. Leucocyte blood picture in healthy full-term and premature babies during neonatal period. Arch Dis Child 1970;45(240):242–9.Google Scholar
Newman, TB, Puopolo, KM, Wi, S, Draper, D, Escobar, GJ. Interpreting complete blood counts soon after birth in newborns at risk for sepsis. Pediatrics 2010; 126(5):903–9.Google Scholar
Hornik, CP, Benjamin, DK, Becker, KC, et al. Use of the complete blood cell count in late-onset neonatal sepsis. Pediatr Infect Dis J 2012;31(8):803–7.Google Scholar
Rastogi, S, Rastogi, D, Sundaram, R, Kulpa, J, Parekh, AJ. Leukemoid reaction in extremely low-birth-weight infants. Am J Perinatol 1999;16(2):93–7 .Google Scholar
Krumbhaar, EB. Leukemoid blood pictures in various clinical conditions. Am J Med Sci 1926;172(4):519–32.Google Scholar
Calhoun, DA, Kirk, JF, Christensen, RD. Incidence, significance, and kinetic mechanism responsible for leukemoid reactions in patients in the neonatal intensive care unit: a prospective evaluation. J Pediatr 1996;129(3):403–9.Google Scholar
Zanardo, V, Savio, V, Giacomin, C, et al. Relationship between neonatal leukemoid reaction and bronchopulmonary dysplasia in low-birth-weight infants: a cross-sectional study. Am J Perinatol 2002;19(7):379–86.Google Scholar
Hsiao, R, Omar, SA. Outcome of extremely low birth weight infants with leukemoid reaction. Pediatrics 2005;116(1):e43-e51.Google Scholar
Zanardo, V, Vedovato, S, Trevisanuto, DD, et al. Histological chorioamnionitis and neonatal leukemoid reaction in low-birth-weight infants. Hum Pathol 2006;37(1):8791.Google Scholar
Henry, E, Walker, D, Wiedmeier, SE, Christensen, RD. Hematological abnormalities during the first week of life among neonates with Down syndrome: Data from a multihospital healthcare system. Am J Med Genet A 2007;143A(1):4250.Google Scholar
Nijhawan, A, Baselga, E, Gonzalez, -Ensenat, MA, et al. Vesiculopustular eruptions in Down syndrome neonates with myeloproliferative disorders. Arch Dermatol 2001;137(6):760–3.Google Scholar
Burch, JM, Weston, WL, Rogers, M, Morelli, JG. Cutaneous pustular leukemoid reactions in trisomy 21. Pediatr Dermatol 2003;20(3):232–7.Google Scholar
Xu, G, Nagano, M, Kanezaki, R, et al. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome. Blood 2003;102(8):2960–8.Google Scholar
Crispino, JD. GATA1 in normal and malignant hematopoiesis. Semin Cell Dev Biol 2005;16(1):137–47.Google Scholar
Engmann, C, Donn, SM. Severe neutrophilia in an infant with persistent pulmonary hypertension of the newborn. Am J Perinatol 2003;20(7):347–51.Google Scholar
Alizadeh, P, Rahbarimanesh, AA, Bahram, MG, Salmasian, H. Leukocyte adhesion deficiency type 1 presenting as leukemoid reaction. Indian J Pediatr 2007;74(12):1121–3.Google Scholar
Lambert, RM, Baer, VL, Wiedmeier, SE, et al. Isolated elevated blood neutrophil concentration at altitude does not require NICU admission if appropriate reference ranges are used. J Perinatol 2009;29(12):822–5.Google Scholar
Wiedmeier, SE, Henry, E, Christensen, RD. Hematological abnormalities during the first week of life among neonates with trisomy 18 and trisomy 13: Data from a multi-hospital healthcare system. Am J Med Genet A 2008;146A(3):312–20.Google Scholar
Brazy, JE, Grimm, JK, Little, VA. Neonatal manifestations of severe maternal hypertension occurring before the thirty-sixth week of pregnancy. J Pediatr 1982;100(2):265–71Google Scholar
Koenig, JM, Christensen, RD. Incidence, neutrophil kinetics, and natural history of neonatal neutropenia associated with maternal hypertension. N Engl J Med 1989;321(9):557–62.Google Scholar
Koenig, JM, Christensen, RD. The mechanism responsible for diminished neutrophil production in neonates delivered of women with pregnancy-induced hypertension. Am J Obstet Gynecol 1991;165(2):467–73.Google Scholar
Doron, MW, Makhlouf, RA, Katz, VL, et al. Increased incidence of sepsis at birth in neutropenic infants of mothers with preeclampsia. J Pediatr 1994;125(3):452–8.Google Scholar
Cadnapaphornchai, M, Faix, RG. Increased nosocomial infection in neutropenic low birth weight (2000 grams or less) infants of hypertensive mothers. J Pediatr 1992;121(6): 956–61.Google Scholar
Koenig, JM, Hunter, DD, Christensen, RD. Neutropenia in donor (anemic) twins involved in the twin-twin transfusion syndrome. J Perinatol 1991;11(4):355–8.Google Scholar
Koenig, JM, Christensen, RD. Neutropenia and thrombocytopenia in infants with Rh hemolytic disease. J Pediatr 1989;114(4 Pt 1):625–31.Google Scholar
Zook, KJ, Mackley, AB, Kern, J, Paul, DA. Hematologic effects of placental pathology on very low birthweight infants born to mothers with preeclampsia. J Perinatol 2009;29(1):812.Google Scholar
Guner, S, Yigit, S, Cetin, M, et al. Evaluation of serum granulocyte colony stimulating factor levels in infants of preeclamptic mothers. Turk J Pediatr 2007;49(1):5560.Google Scholar
Tsao, PN, Teng, R-J, Tang, J-R, Yau, K-I T. Granulocyte colony-stimulating factor in the cord blood of premature neonates born to mothers with pregnancy-induced hypertension. J Pediatr 1999;135(1):56–9.Google Scholar
Manzoni, P, Farina, D, Monetti, C, et al. Early-onset neutropenia is a risk factor for Candida colonization in very low-birth-weight neonates. Diagn Microbiol Infect Dis 2007;57(1):7783.Google Scholar
Teng, RJ, Wu, TJ, Garrison, RD, Sharma, R, Huday, ML. Early neutropenia is not associated with an increased rate of nosocomial infection in very low-birth-weight infants. J Perinatol 2009;29(3):219–24.Google Scholar
Ahmad, M, Fleit, HB, Golightly, MG, LaGamma, EF. In vivo effect of recombinant human granulocyte colony-stimulating factor on phagocytic function and oxidative burst activity in septic neutropenic neonates. Biol Neonate 2004;86(1):4854.Google Scholar
Zuppa, AA, Girlando, P, Florio, MG, et al. Influence of maternal preeclampsia on recombinant human granulocyte colony-stimulating factor effect in neutropenic neonates with suspected sepsis. Eur J Obstet Gynecol Reprod Biol 2002;102(2):131–6.Google Scholar
Kocherlakota, P, La Gamma, EF. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia. Pediatrics 1998;102(5):1107–11.Google Scholar
Shankaran, S, Pappas, A, Laptook, AR, et al. Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy. Pediatrics 2008;122(4):e791–8.Google Scholar
Azzopardi, DV, Strohm, B, Edwards, AD, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009;361(14):1349–58.Google Scholar
Jacobs, SE, Morley, CJ, Inder, TE, et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: A randomized controlled trial. Arch Pediatr Adolesc Med 2011;165(8):692700.Google Scholar
Simbruner, G, Mittal, RA, Rohlmann, F, et al. Systemic hypothermia after neonatal encephalopathy: Outcomes of neo.nEURO.network RCT. Pediatrics 2010;126(4):e771–8.Google Scholar
Jenkins, DD, Lee, T, Chiuzan, C, et al. Altered circulating leukocytes and their chemokines in a clinical trial of therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy*. Pediatr Crit Care Med 2013;14(8):786–95Google Scholar
Cybulsky, MI, Movat, HZ. Experimental bacterial pneumonia in rabbits: Polymorphonuclear leukocyte margination and sequestration in rabbit lungs and quantitation and kinetics of 51Cr-labeled polymorphonuclear leukocytes in E. coli-induced lung lesions. Exp Lung Res 1982;4(1):4766.Google Scholar
Erdman, SH, Christensen, RD, Bradley, PP, Rothstein, G. Supply and release of storage neutrophils. A developmental study. Biol Neonate 1982;41(3–4):132–7Google Scholar
Christensen, RD, Rothstein, G. Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr 1980;96(2):316–18.Google Scholar
Christensen, RD. Neutrophil kinetics in the fetus and neonate. Am J Pediatr Hematol Oncol 1989;11(2):215–23.Google Scholar
al-Mulla, ZS, Christensen, RD. Neutropenia in the neonate. Clin Perinatol 1995;22(3):711–39.Google Scholar
Rodwell, RL, Taylor, K, Tudehope, D, Gray, P. Hematologic scoring system in early diagnosis of sepsis in neutropenic newborns. Pediatr Infect Dis J 1993;12(5):372–6.Google Scholar
Carr, R. Neutrophil production and function in newborn infants. Br J Haematol 2000;110(1):1828.Google Scholar
Maheshwari, A, Christensen, RD. Developmental granulopoiesis. In Polin, RA, Fox, WW, Abman, SH, eds. Fetal and Neonatal Physiology (Philadelphia, PA: Saunders, 2004).Google Scholar
Boxer, LA, Yokoyama, M, Lalezari, P. Isoimmune neonatal neutropenia. J Pediatr 1972;80(5):783–7.Google Scholar
Lalezari, P, Radel, E. Neutrophil-specific antigens: Immunology and clinical significance. Semin Hematol 1974;11(3):281–90.Google Scholar
Levine, DH, Madyastha, PR. Isoimmune neonatal neutropenia. Am J Perinatol 1986;3(3):231–3.Google Scholar
Conway, LT, Clay, ME, Kline, WE, et al. Natural history of primary autoimmune neutropenia in infancy. Pediatrics 1987;79(5):728–33.Google Scholar
Lalezari, P, Khorshidi, M, Petrosova, M. Autoimmune neutropenia of infancy. J Pediatr 1986;109(5):764–9.Google Scholar
Veldhuisen, B, Porcelijn, L, Ellen van der Schoot, C, de Haas, M. Molecular typing of human platelet and neutrophil antigens (HPA and HNA). Transfus Apher Sci 2014;50(2):189–99.Google Scholar
Boxer, LA, Greenberg, MS, Boxer, GJ, Stossel, TP. Autoimmune neutropenia. N Engl J Med 1975;293(15):748–53.Google Scholar
Lyall, EG, Lucas, GF, Eden, OB. Autoimmune neutropenia of infancy. J Clin Pathol 1992;45(5):431–4.Google Scholar
Bux, J. Molecular nature of granulocyte antigens. Transfus Clin Biol 2001;8(3):242–7.Google Scholar
Farruggia, P. Immune neutropenias of infancy and childhood. World J Pediatr 2016;12(2):142–8.Google Scholar
Horwitz, M, Benson, K, Person, R, et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 1999;23(4): 433–6.Google Scholar
Dale, DC, Person, RE, Bolyard, AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 2000;96(7):2317–22.Google Scholar
Beekman, R, Touw, IP. G-CSF and its receptor in myeloid malignancy. Blood 2010;115(25):5131–6.Google Scholar
Link, DC, Kunter, G, Kasai, Y, et al. Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood 2007;110(5):1648–55.Google Scholar
Skokowa, J, Steinemann, D, Katsman, -Kuipers, JE, et al. Cooperativity of RUNX1 and CSF3 R mutations in severe congenital neutropenia: A unique pathway in myeloid leukemogenesis. Blood 2014;123(14): 2229–37.Google Scholar
Kostmann, R. Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr Suppl 1956;45(Suppl 105):178.Google Scholar
Bonilla, MA, Gillio, AP, Ruggeiro, M, et al. Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis. N Engl J Med 1989;320(24):1574–80.Google Scholar
Dale, DC, Bolyard, AA, Hammond, WP. Cyclic neutropenia: Natural history and effects of long-term treatment with recombinant human granulocyte colony-stimulating factor. Cancer Invest 1993;11(2):219–23.Google Scholar
Makaryan, V, Zeidler, C, Bolyard, AA, et al. The diversity of mutations and clinical outcomes for ELANE-associated neutropenia. Curr Opin Hematol 2015;22(1):311.Google Scholar
Shwachman, H, Diamond, LK, Oski, FA, Khaw, KT. The syndrome of pancreatic insufficiency and bone marrow dysfunction. J Pediatr 1964;65:645–63.Google Scholar
Burroughs, L, Woolfrey, A, Shimamura, A. Shwachman–Diamond syndrome: A review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol Oncol Clin North Am 2009;23(2):233–48.Google Scholar
Boocock, GR, Morrison, JA, Popovic, M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 2003;33(1):97101.Google Scholar
Ganapathi, KA, Austin, KM, Lee, CS, et al. The human Shwachman–Diamond syndrome protein, SBDS, associates with ribosomal RNA. Blood 2007;110(5):1458–65.Google Scholar
Rujkijyanont, P, Adams, S‐L, Beyene, J, Dror, Y. Bone marrow cells from patients with Shwachman–Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing. Br J Haematol 2009;145(6):806–15.Google Scholar
Roper, M, Parmley, RT, Crist, WM, Kelly, DR, Cooper, MD. Severe congenital leukopenia (reticular dysgenesis).Immunologic and morphologic characterizations of leukocytes. Am J Dis Child 1985;139(8):832–5.Google Scholar
Bertrand, Y, Müller, S, Casanova, J, et al. Reticular dysgenesis: HLA non-identical bone marrow transplants in a series of 10 patients. Bone Marrow Transplant 2002;29(9):759–62.Google Scholar
Christensen, RD, Henry, E, Wiedmeier, SE, Stoddard, RA, Lambert, DK. Low blood neutrophil concentrations among extremely low birth weight neonates: data from a multihospital health-care system. J Perinatol 2006;26(11):682–7.Google Scholar
Juul, SE, Calhoun, DA, Christensen, RD. “Idiopathic neutropenia” in very low birthweight infants. Acta Paediatr 1998;87(9):963–8.Google Scholar
Juul, SE, Christensen, RD. Effect of recombinant granulocyte colony-stimulating factor on blood neutrophil concentrations among patients with “idiopathic neonatal neutropenia”: A randomized, placebo-controlled trial. J Perinatol 2003;23(6):493–7.Google Scholar
Rivers, A, Slayton, WB. Congenital cytopenias and bone marrow failure syndromes. Semin Perinatol 2009;33(1):20–8.Google Scholar
Nittala, S, Subbarao, GC, Maheshwari, A. Evaluation of neutropenia and neutrophilia in preterm infants. J Matern Fetal Neonatal Med 2012;25(Suppl 5):100–3.Google Scholar
Corey, SJ, Wollman, MR, Deshpande, RV. Granulocyte colony-stimulating factor and congenital neutropenia–risk of leukemia? J Pediatr 1996;129(1):187–8.Google Scholar
Sullivan, SE, Calhoun, DA. Eosinophilia in the neonatal intensive care unit. Clin Perinatol 2000; 27(3): 603–22, vi.Google Scholar
Pammi, M, Brocklehurst, P. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia. Cochrane Database Syst Rev 2011;10:CD003956.Google Scholar
Ohlsson, A, Lacy, JB. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst Rev, 2004;1:CD000361.Google Scholar
Ohlsson, A, Lacy, JB. Intravenous immunoglobulin for suspected or proven infection in neonates. Cochrane Database Syst Rev, 2015;3:CD001239.Google Scholar
Inis Collaborative Group, Brocklehurst, P, Farrell, B, et al. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med 2011;365(13):1201–11.Google Scholar

References

Orkin, SH, Fisher, DE, Ginsburg, D, et al. eds.Nathan and Oski’s Hematology and Oncology of Infancy and Childhood. 8th ed. (Philadelphia PA: Saunders/Elsevier, 2015).Google Scholar
Urlichs, F, Speer, CP. Neutrophil function in preterm and term infants. NeoReviews 2004 ;5(10): e417e430.Google Scholar
Lawrence, SM, Corriden, R, Nizet, V. Age-appropriate functions and dysfunctions of the neonatal neutrophil. Front Pediatr 2017;5:23.Google Scholar
Melvan, JN, Bagby, GJ, Welsh, DA, Nelson, S, Zhang, P. Neonatal sepsis and neutrophil insufficiencies. Int Rev Immunol 2010;29(3):315–48.Google Scholar
Levy, O. Innate immunity of the newborn: Basic mechanisms and clinical correlates. Nat Rev Immunol 2007;7(5):379–90.Google Scholar
Carr, R. Neutrophil production and function in newborn infants. BJHaem 2000;110(1):1828.Google Scholar
Chandra, S, Haines, H, Michie, C, Maheshwari, A. Developmental defects in neutrophils from preterm infants. NeoReviews 2007;8(9):e368–76.Google Scholar
Lipp, P, Ruhnau, J, Lange, A, et al. Less neutrophil extracellular trap formation in term newborns than in adults. Neonatology 2017;111(2):182–8.Google Scholar
Chaudhuri, J, Mitra, S, Mukhopadhyay, D, Chakraborty, S, Chatterjee, S. Granulocyte colony-stimulating factor for preterms with sepsis and neutropenia: A randomized controlled trial. J Clin Neonatol 2012;1(4):202–6.Google Scholar
Aktaş, D, Demirel, B, Gürsoy, T, Ovalı, F. A randomized case-controlled study of recombinant human granulocyte colony stimulating factor for the treatment of sepsis in preterm neutropenic infants. Pediatr Neonatol 2015;56(3):171–5.Google Scholar
Carr, R, Modi, N, Doré, C. G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev 2003;3: CD003066.Google Scholar
Carr, R, Brocklehurst, P, Doré, CJ, Modi, N. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicentre, randomised controlled trial. Lancet 2009;373(9659):226–33.Google Scholar
Capasso, L, Borrelli, A, Cerullo, J, et al. Role of immunoglobulins in neonatal sepsis. Transl Med UniSa 2015;11:2833.Google Scholar
Franco, ACBF, Torrico, AC, Moreira, FT, et al. Adjuvant use of intravenous immunoglobulin in the treatment of neonatal sepsis: A systematic review with a meta-analysis. J Pediatr (Rio J) 2012;88(5):377–83.Google Scholar
INIS Collaborative Group, Brocklehurst, P, Farrell, B, et al. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med 2011;365(13):1201–11.Google Scholar
Jenson, HB, Pollock, BH. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. Pediatrics 1997;99(2):E2.Google Scholar
Jenson, HB, Pollock, BH. The role of intravenous immunoglobulin for the prevention and treatment of neonatal sepsis. Semin Perinatol 1998;22(1):5063.Google Scholar
Ohlsson, A, Lacy, JB. Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2013;2(7):CD000361.Google Scholar
Glocker, E-O, Hennigs, A, Nabavi, M, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009;361(18):1727–35.Google Scholar
Netea, MG, Maródi, L. Innate immune mechanisms for recognition and uptake of Candida species. Trends Immunol 2010;31(9):346–53.Google Scholar
Clark, RA, Kimball, HR. Defective granulocyte chemotaxis in the Chediak–Higashi syndrome. J Clin Invest 1971;50(12):2645–52.Google Scholar
Kaplan, J, De Domenico, I, Ward, DM. Chediak–Higashi syndrome. Curr Opin Hematol 2008;15(1):22–9.Google Scholar
Gallin, JI, Elin, RJ, Hubert, RT, et al. Efficacy of ascorbic acid in Chediak–Higashi syndrome (CHS): Studies in humans and mice. Blood. 1979;53(2):226–34.Google Scholar
Boxer, LA, Watanabe, AM, Rister, M, et al. Correction of leukocyte function in Chediak–Higashi syndrome by ascorbate. N Engl J Med 1976;295(19):1041–5.Google Scholar
Boxer, LA, Albertini, DF, Baehner, RL, Oliver, JM. Impaired microtubule assembly and polymorphonuclear leucocyte function in the Chediak–Higashi syndrome correctable by ascorbic acid. Br J Haematol 1979;43(2):207–13.Google Scholar
Winkelstein, JA, Marino, MC, Johnston, RB, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 2000;79(3):155–69.Google Scholar
Marciano, BE, Spalding, C, Fitzgerald, A, et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis 201515;60(8):1176–83.Google Scholar
Marciano, BE, Rosenzweig, SD, Kleiner, DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 2004;114(2):462–8.Google Scholar
Kuhns, DB, Alvord, WG, Heller, T, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 2010;363(27):2600–10.Google Scholar
Gallin, JI, Alling, DW, Malech, HL, et al. Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 2003;348(24):2416–22.Google Scholar
The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med 1991;324(8):509–16.Google Scholar
Güngör, T, Teira, P, Slatter, M, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet 2014;383(9915):436–48.Google Scholar
Visser, G, Rake, JP, Fernandes, J, et al. Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: Results of the European study on glycogen storage disease type I. J Pediatr 2000;137(2):187–91.Google Scholar
Melis, D, Fulceri, R, Parenti, G, et al. Genotype/phenotype correlation in glycogen storage disease type 1b: A multicentre study and review of the literature. Eur J Pediatr 2005;164(8):501–8.Google Scholar
Sowerwine, KJ, Holland, SM, Freeman, AF. Hyper-IgE syndrome update. Ann N Y Acad Sci 2012;1250:2532.Google Scholar
Hill, HR, Ochs, HD, Quie, PG, et al. Defect in neutrophil granulocyte chemotaxis in Job’s syndrome of recurrent “cold” staphylococcal abscesses. Lancet 1974;2(7881):617–19.Google Scholar
Dinauer, MC. Disorders of neutrophil function: An overview. Methods Mol Biol 2007;412:489504.Google Scholar
Szczawinska-Poplonyk, A, Kycler, Z, Pietrucha, B, et al. The hyperimmunoglobulin E syndrome: Clinical manifestation diversity in primary immune deficiency. Orphanet J Rare Dis 2011;6(1):76.Google Scholar
Sassi, A, Lazaroski, S, Wu, G, et al. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels. J Allergy Clin Immunol. 2014;133(5):1410–19.E13.Google Scholar
Zhang, Y, Yu, X, Ichikawa, M, et al. Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment. J Allergy Clin Immunol 2014;133(5):1400–9, e14095.Google Scholar
Mogensen, TH. STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties. JAKSTAT. 2013;2(2):e23435.Google Scholar
Davies, EG, Thrasher, AJ. Update on the hyper immunoglobulin M syndromes. Br J Haematol 2010;149(2):167–80.Google Scholar
Picard, C, von Bernuth, H, Ghandil, P, et al. Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency. Medicine (Baltimore) 2010;89(6):403–25.Google Scholar
Bouma, G, Doffinger, R, Patel, SY, et al. Impaired neutrophil migration and phagocytosis in IRAK-4 deficiency. Br J Haematol 2009;147(1):153–6.Google Scholar
Jarchum, I, Liu, M, Shi, C, Equinda, M, Pamer, EG. Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis. Infect Immun 2012;80(9):2989–96.Google Scholar
Harris, ES, Weyrich, AS, Zimmerman, GA. Lessons from rare maladies: Leukocyte adhesion deficiency syndromes. Curr Opin Hematol 2013;20(1):1625.Google Scholar
Rotrosen, D, Gallin, JI. Disorders of phagocyte function. Annu Rev Immunol 1987;5:127–50.Google Scholar
Moutsopoulos, NM, Konkel, J, Sarmadi, M, et al. Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss. Sci Transl Med 2014;6(229):229ra40.Google Scholar
Bustamante, J, Boisson-Dupuis, S, Abel, L, Casanova, J-L. Mendelian susceptibility to mycobacterial disease: Genetic, immunological, and clinical features of inborn errors of IFN-γ immunity. Semin Immunol 2014;26(6):454–70.Google Scholar
Bigley, V, Maisuria, S, Cytlak, U, et al. Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation. Journal of Allergy and Clinical Immunology 2018;141(6):2234–48.Google Scholar
Klebanoff, SJ, Kettle, AJ, Rosen, H, Winterbourn, CC, Nauseef, WM. Myeloperoxidase: A front-line defender against phagocytosed microorganisms. J Leukoc Biol 2013;93(2):185–98.Google Scholar
Chiang, AK, Chan, GC, Ma, SK, et al. Disseminated fungal infection associated with myeloperoxidase deficiency in a premature neonate. Pediatr Infect Dis J 2000;19(10):1027–9.Google Scholar
Ludviksson, BR, Thorarensen, O, Gudnason, T, Halldorsson, S. Candida albicans meningitis in a child with myeloperoxidase deficiency. Pediatr Infect Dis J 1993;12(2):162–4.Google Scholar
Uzel, G. The range of defects associated with nuclear factor kappaB essential modulator. Curr Opin Allergy Clin Immunol 2005;5(6):513–18.Google Scholar
Kawai, T, Nishikomori, R, Heike, T. Diagnosis and treatment in anhidrotic ectodermal dysplasia with immunodeficiency. Allergol Int 2012;61(2):207–17.Google Scholar
Choi, M, Rolle, S, Wellner, M, et al. Inhibition of NF-kappaB by a TAT-NEMO-binding domain peptide accelerates constitutive apoptosis and abrogates LPS-delayed neutrophil apoptosis. Blood 2003;102(6):2259–67.Google Scholar
Singh, A, Zarember, KA, Kuhns, DB, Gallin, JI. Impaired priming and activation of the neutrophil NADPH oxidase in patients with IRAK4 or NEMO deficiency. J Immunol 2009;182(10):6410–17.Google Scholar
Pai, S-Y, Levy, O, Jabara, HH, et al. Allogeneic transplantation successfully corrects immune defects, but not susceptibility to colitis, in a patient with nuclear factor-kappaB essential modulator deficiency. J Allergy Clin Immunol 2008;122(6):1113–1118.e1.Google Scholar
Dupuis-Girod, S, Cancrini, C, Le Deist, F, et al. Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency. Pediatrics 2006;118(1):e205211.Google Scholar
Gallin, JI, Fletcher, MP, Seligmann, BE, et al. Human neutrophil-specific granule deficiency: a model to assess the role of neutrophil-specific granules in the evolution of the inflammatory response. Blood 1982;59(6):1317–29.Google Scholar
McIlwaine, L, Parker, A, Sandilands, G, Gallipoli, P, Leach, M. Neutrophil-specific granule deficiency. Br J Haematol 2013;160(6):735.Google Scholar
Wynn, RF, Sood, M, Theilgaard-Mönch, K, et al. Intractable diarrhoea of infancy caused by neutrophil specific granule deficiency and cured by stem cell transplantation. Gut 2006;55(2):292–3.Google Scholar
Dhanraj, S, Matveev, A, Li, H, et al. Biallelic mutations in DNAJC21 cause Shwachman–Diamond syndrome. Blood 2017;129(11):1557–62.Google Scholar
Stepensky, P, Chacón-Flores, M, Kim, KH, et al. Mutations in EFL1, an SBDS partner, are associated with infantile pancytopenia, exocrine pancreatic insufficiency and skeletal anomalies in a Shwachman-Diamond like syndrome. J Med Genet 2017 54(8):558–66.Google Scholar
Carapito, R, Konantz, M, Paillard, C, et al. Mutations in signal recognition particle SRP54 cause syndromic neutropenia with Shwachman–Diamond-like features. J Clin Invest 2017;127(11):4090–103.Google Scholar
Bezzerri, V, Cipolli, M. Shwachman–Diamond syndrome: Molecular mechanisms and current perspectives. Mol Diagn Ther 2019;23(2):281–90.Google Scholar
Rochowski, A, Sun, C, Glogauer, M, Alter, BP. Neutrophil functions in patients with inherited bone marrow failure syndromes. Pediatr Blood Cancer 2011;57(2):306–9.Google Scholar
Nelson, AS, Myers, KC. Diagnosis, treatment, and molecular pathology of Shwachman–Diamond syndrome. Hematol Oncol Clin North Am 2018;32(4):687700.Google Scholar
Thrasher, AJ, Burns, SO. WASP: a key immunological multitasker. Nat Rev Immunol 2010;10(3):182–92.Google Scholar
Ochs, HD, Slichter, SJ, Harker, LA, et al. The Wiskott–Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood 1980;55(2):243–52.Google Scholar
Massaad, MJ, Ramesh, N, Geha, RS. Wiskott–Aldrich syndrome: A comprehensive review. Ann N Y Acad Sci 2013;1285:2643. Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×